drug

copper histidinate

Marketedupdated 2mo ago

by Sentynl Therapeutics Inc

Approved

community read0 votes

all catalysts(1)

approval · 1

Jan 12, 2026

approval

6mo ago

ZYCUBO (COPPER HISTIDINATE) — FDA approval

copper histidinate

→

News(0)

no news has mentioned this drug yet

comments(0)

5-min edit window · permanent after that

sign in to leave a comment · permanent archive after 5 minutes

no comments yet — first sniff?

Data sources

openFDA · ClinicalTrials.gov

last refreshed 1h ago

Found something off?

Patent cliff

source: FDA Orange Book

first barrier falls

Jan 12, 2031

~4.5 years out

Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.

FDA exclusivities (1)

Jan 12, 2031NCENew Chemical Entity (5y)4.5y

🐶 often sniffed alongside

top 2

Trials studying copper histidinate

—Copper Histidinate Treatment for Menkes Diseaseapproved for marketing